AKR1C3 and carcinoma: A very recent survey of the expression of AKR1C3 in 2490 surgical samples from 19 types of cancer revealed a strikingly elevated expression of AKR1C3 in a subset of hepatocellular (58%); bladder and gastric (>50%); and non-small cell lung (48%) carcinomas [37].